InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
-17.5%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by ROBERTS LEE D, Director. Insider active across 2 companies, notably Inovalon Holdings, Inc.. Cumulatively, 15 disclosures have been recorded. Breakdown: 5 buys · 0 sell. Total volume traded: €780k. Activity tracked since 5 November 2021. The latest transaction was filed on 24 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations15 total
44,643 shares0Common StockSEC:0001062993-25-003720:0
36,037 shares0Common StockSEC:0001062993-24-004756:0
40,161 shares0Common StockSEC:0001857647-23-000022:0
20,000 shares@ US$4.3710.7% of flowCommon StockSEC:0001838400-22-000007:0
Ideal exit: 28 Aug 2023 (T+270)
9,187 shares0Common StockSEC:0001857647-22-000027:0
9,187 shares0Common StockSEC:0001857647-22-000014:0
140,532 shares@ US$41.0050.0% of flowClass A Common StockSEC:0001619954-21-000151
140,532 shares@ US$41.0050.0% of flowClass A Common StockSEC:0001619954-21-000151:0
10,000 shares@ US$18.466621.1% of flowCommon StockSEC:0000746838-21-000087
Ideal exit: 20 Aug 2022 (T+270)
10,000 shares@ US$18.46660.075% mcap23.6% of flowCommon StockSEC:0000746838-21-000087:0
Ideal exit: 20 Aug 2022 (T+270)
10,000 shares@ US$21.250.084% mcap26.4% of flowCommon StockSEC:0001739045-21-000007:0
Ideal exit: 2 Aug 2022 (T+270)
10,000 shares@ US$21.2523.6% of flowCommon StockSEC:0001739045-21-000007
Ideal exit: 2 Aug 2022 (T+270)
9,165 sharesClass A Common StockSEC:0001619954-21-000100:0
9,165 sharesClass A Common StockSEC:0001619954-21-000100
15,000 sharesCommon StockSEC:0001127602-16-041330:0
15 of 15 declarations
About ROBERTS LEE D
Lee D Roberts is a Director at Inovalon Holdings, Inc. and UNISYS CORP. In these roles, he participates in the governance and strategy of these companies. His experience in the health technology and IT services sectors is valuable in guiding strategic decisions.
